News

The Malaysian Reserve21h

Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma

Superior efficacy shown in two head-to-head phase III trials, including overall survival in DREAMM-7  Blenrep combinations ...